GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis

European Journal of Cancer

Volumn 47, Issue 11, 2011, Pages 1699-1707

  Xing, Jinliang ^a   Myers, Ronald E ^b   He, Xianli ^c   Qu, Falin ^c   Zhou, Feng ^c   Ma, Xi ^a   Hyslop, Terry ^b   Bao, Guoqiang ^c   Wan, Shaogui ^b   Yang, Hushan ^b   Chen, Zhinan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Prognosis; Single nucleotide polymorphism

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 10P; CHROMOSOME 15Q; COLORECTAL CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 79960026089     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.02.004     Document Type: Article

References (30)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 2010 765 781
2. H.E. Karim-Kos, E. de Vries, and I. Soerjomataram Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 10 2008 1345 1389
3. L. Yang, D.M. Parkin, J. Ferlay, L. Li, and Y. Chen Estimates of cancer incidence in China for 2000 and projections for 2005 Cancer Epidemiol Biomarkers Prev 14 1 2005 243 250 (Pubitemid 40165308)
4. L. Yang, D.M. Parkin, L. Li, and Y. Chen Time trends in cancer mortality in China: 1987-1999 Int J Cancer 106 5 2003 771 783 (Pubitemid 37006314)
5. C.C. Compton, L.P. Fielding, and L.J. Burgart Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 7 2000 979 994 (Pubitemid 30602039)
6. G.J. Chang, C.Y. Hu, C. Eng, J.M. Skibber, and M.A. Rodriguez-Bigas Practical application of a calculator for conditional survival in colon cancer J Clin Oncol 27 35 2009 5938 5943
7. C.M. Ulrich, K. Robien, and H.L. McLeod Cancer pharmacogenetics: polymorphisms, pathways and beyond Nat Rev Cancer 3 12 2003 912 920 (Pubitemid 37500176)
8. A. Naccarati, B. Pardini, K. Hemminki, and P. Vodicka Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms Mutat Res 635 2-3 2007 118 145 (Pubitemid 46756400)
9. M.R. Spitz, X. Wu, and G. Mills Integrative epidemiology: from risk assessment to outcome prediction J Clin Oncol 23 2 2005 267 275 (Pubitemid 46206878)
10. Y.C. Wang, H.S. Lee, S.K. Chen, Y.Y. Chang, and C.Y. Chen Prognostic significance of p53 codon 72 polymorphism in lung carcinomas Eur J Cancer 35 2 1999 226 230
11. J.Y. Han, G.K. Lee, D.H. Jang, S.Y. Lee, and J.S. Lee Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer Cancer 113 4 2008 799 807
12. X. Wu, C. Lu, and Y. Ye Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy Pharmacogenet Genomics 18 11 2008 955 965
13. M.E. Zafereo, E.M. Sturgis, and Z. Liu Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck Carcinogenesis 30 6 2009 997 1002
14. I. Yaylim-Eraltan, S. Arikan, and Y. Yildiz The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population Anticancer Res 30 7 2010 2875 2880
15. W. Zhang, M. Gordon, and O.A. Press Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab Pharmacogenet Genomics 16 7 2006 475 483 (Pubitemid 43922345)
16. J. Jiang, J. Wang, and S. Suzuki Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population J Cancer Res Clin Oncol 132 3 2006 193 199 (Pubitemid 43015780)
17. S. Siena, A. Sartore-Bianchi, F. Di Nicolantonio, J. Balfour, and A. Bardelli Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer J Natl Cancer Inst 101 19 2009 1308 1324
18. N. Normanno, S. Tejpar, and F. Morgillo Implications for KRAS status and EGFR-targeted therapies in metastatic CRC Nat Rev Clin Oncol 6 9 2009 519 527
19. I.P. Tomlinson, E. Webb, and L. Carvajal-Carmona A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 Nat Genet 40 5 2008 623 630 (Pubitemid 351601204)
20. P. Broderick, L. Carvajal-Carmona, and A.M. Pittman A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk Nat Genet 39 11 2007 1315 1317 (Pubitemid 350034998)
21. A. Tenesa, S.M. Farrington, and J.G. Prendergast Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 Nat Genet 40 5 2008 631 637 (Pubitemid 351601219)
22. E. Jaeger, E. Webb, and K. Howarth Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk Nat Genet 40 1 2008 26 28
23. W.J. Kent, C.W. Sugnet, and T.S. Furey The human genome browser at UCSC Genome Res 12 6 2002 996 1006 (Pubitemid 34662293)
24. A. Siepel, G. Bejerano, and J.S. Pedersen Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes Genome Res 15 8 2005 1034 1050 (Pubitemid 41126859)
25. M.M. Pomerantz, N. Ahmadiyeh, and L. Jia The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer Nat Genet 41 8 2009 882 884
26. H. Shima, T. Hiyama, and S. Tanaka Loss of heterozygosity on chromosome 10p14-p15 in colorectal carcinoma Pathobiology 72 4 2005 220 224 (Pubitemid 41225247)
27. J.B. Sneddon, H.H. Zhen, and K. Montgomery Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation Proc Natl Acad Sci USA 103 40 2006 14842 14847 (Pubitemid 44527816)
28. A. Waha, A. Koch, and W. Hartmann SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas Oncogene 26 38 2007 5662 5668 (Pubitemid 47267832)
29. W. Wang, M.R. Spitz, and H. Yang Genetic variants in cell cycle control pathway confer susceptibility to lung cancer Clin Cancer Res 13 19 2007 5974 5981 (Pubitemid 47583926)
30. I.B. Runnebaum, S. Wang-Gohrke, and D. Vesprini Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives Pharmacogenetics 11 7 2001 635 638 (Pubitemid 32953589)